LFST LifeStance Health Group Earnings and EPS analysis

?
Relative Growth: Rel. Growth: 87
Relative Strength: Rel. Strength: 94
Relative Valuation: Rel. Valuation: 50
Relative Profitability: Rel. Profitability: 60

EPS in 2026 (TTM): $0.14

Last Report Period Date: Jun 30, 2026

According to the most recent financial data from June 2026, the EPS for the trailing twelve months is $0.14. LifeStance Health Group's EPS for 2025 amounted to $0.03, marking an increase from -$0.15 in 2024. During the quarterly period ending on Jun 30, 2026, LFST's EPS stood at $0.06.

LFST earnings history

Historical annual and quarterly earnings per share (EPS) data for LifeStance Health Group
EPS (TTM)
$0.14
EPS Growth YoY (Quarterly)
700%
EPS (Quarterly)
$0.06
EPS Growth (Quarterly)
50%

LifeStance Health Group had an annual EPS of $0.03, indicating an increase of 120% from -$0.15 in 2024. The quarterly per-share earnings for the period ending Jun 30, 2026, was $0.06, indicating a 700% increase from the same quarter last year. LFST's 12-month EPS stands at $0.14 as of June 2026. LifeStance Health Group's annual EPS in 2024 stood at -$0.15, a 70.6% increase year-over-year.

LFST EPS vs price chart

LFST EPS growth history

Earnings per share growth rates over time
EPS Growth YoY (Quarterly)
700%
EPS growth YoY
120%
EPS growth 3Y avg
N/A
EPS growth 5Y avg
N/A

During the last 12 months, LifeStance Health Group has seen an EPS growth of 700% (YoY, quarterly).

LFST Earnings Waterfall

Breakdown of revenue, profit and net income for LifeStance Health Group

All data is based on quarterly TTM periods, unless otherwise specified.